Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis
F Andreotti, B Rocca, S Husted, RA Ajjan… - European heart …, 2015 - academic.oup.com
Contemporary medicine is shifting towards person rather than disease-oriented care. 1 With
increasing life expectancy and the ageing of baby boomers, the proportion over 60 years is …
increasing life expectancy and the ageing of baby boomers, the proportion over 60 years is …
Aspirin for the prevention of cancer incidence and mortality: systematic evidence reviews for the US Preventive Services Task Force
J Chubak, EP Whitlock, SB Williams… - Annals of internal …, 2016 - acpjournals.org
Background: Cancer is the second leading cause of death in the United States. Purpose: To
conduct systematic reviews of aspirin and 1) total cancer mortality and incidence in persons …
conduct systematic reviews of aspirin and 1) total cancer mortality and incidence in persons …
Aspirin use to prevent cardiovascular disease and colorectal cancer: updated evidence report and systematic review for the US preventive services task force
JM Guirguis-Blake, CV Evans, LA Perdue, SI Bean… - Jama, 2022 - jamanetwork.com
Importance Low-dose aspirin is used for primary cardiovascular disease prevention and
may have benefits for colorectal cancer prevention. Objective To review the benefits and …
may have benefits for colorectal cancer prevention. Objective To review the benefits and …
[HTML][HTML] Effect of aspirin on disability-free survival in the healthy elderly
Background Information on the use of aspirin to increase healthy independent life span in
older persons is limited. Whether 5 years of daily low-dose aspirin therapy would extend …
older persons is limited. Whether 5 years of daily low-dose aspirin therapy would extend …
[PDF][PDF] 2016 European Guidelines on cardiovascular disease prevention in clinical practice
MF Piepoli, AW Hoes, S Agewall… - Polish Heart …, 2016 - journals.viamedica.pl
2.3. 9. Wnioski................................................ 838 2.4. Inne markery ryzyka.......................................
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …
[HTML][HTML] Guidelines: Editor's choice: 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European …
The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …
for personal and educational use only. No commercial use is authorized. No part of the ESC …
Psychometric properties of a short form of the Center for Epidemiologic Studies Depression (CES-D-10) scale for screening depressive symptoms in healthy …
Abstract Background The 10-item Center for the Epidemiological Studies of Depression
Short Form (CES-D-10) is a widely used self-report measure of depression symptomatology …
Short Form (CES-D-10) is a widely used self-report measure of depression symptomatology …
2016 European Guidelines on cardiovascular disease prevention in clinical practice
MF Piepoli - International Journal of Behavioral Medicine, 2017 - search.proquest.com
Cardiovascular disease (CVD) prevention is defined as a coordinated set of actions, at the
population level or targeted at an individual, that are aimed at eliminating or minimizing the …
population level or targeted at an individual, that are aimed at eliminating or minimizing the …
Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial
ASPREE Investigator Group - Contemporary clinical trials, 2013 - Elsevier
Cost-effective strategies to maintain healthy active lifestyle in aging populations are required
to address the global burden of age-related diseases. ASPREE will examine whether the …
to address the global burden of age-related diseases. ASPREE will examine whether the …
[HTML][HTML] The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low‐dose aspirin in patients with and without diabetes
B Rocca, F Santilli, D Pitocco, L Mucci… - Journal of Thrombosis …, 2012 - Elsevier
See also Lordkipanidze M, Harrison P. Aspirin twice a day keeps new COX‐1 at bay. This
issue, pp 1217–9. Summary Background Interindividual variability in response to aspirin has …
issue, pp 1217–9. Summary Background Interindividual variability in response to aspirin has …